NASDAQ: PRPH - ProPhase Labs, Inc.

六个月盈利: -83.64%
股息率: 0.00%
部门: Healthcare

促销时间表 ProPhase Labs, Inc.


关于公司 ProPhase Labs, Inc.

ProPhase Labs, Inc. engages in the development and commercialization of novel drugs, dietary supplements, and compounds in the United States. The company operates in two segments, Diagnostic Services and Consumer Products. It provides a range of OTC dietary supplements, including Legendz XL for male sexual health; and Triple Edge XL, an energy and stamina booster.

更多详情
The company also offers contract manufacturing services, such as consumer product development, pre-commercialization, production, warehousing, and distribution; COVID-19 diagnostic information services to a range of customers, including health plans, third party payers, and government organizations; and respiratory pathogen panel molecular testing services, as well as personal genomics products and services. In addition, it is involved in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements; and retail operations. The company was formerly known as The Quigley Corporation. ProPhase Labs, Inc. was founded in 1989 and is headquartered in Garden City, New York.

IPO date 1997-01-16
ISIN US74345W1080
Industry Pharmaceuticals
Sector Health Care
Валюта usd
Валюта отчета usd
Див.доход ао 0
Дивиденд ао 0.3
Сайт https://www.prophaselabs.com
Цена ао 0.4257
每日价格变化: -7.78% (0.4257)
每周价格变化: -5.63% (0.416)
每月价格变化: +39.96% (0.2805)
3个月内价格变化: -39.69% (0.651)
六个月内的价格变化: -83.64% (2.4)
每年价格变化: -92.21% (5.04)
3年内价格变化: -94.05% (6.6)
5年内价格变化: -77.88% (1.7752)
年初以来价格变化: -39.89% (0.6531)

低估

姓名 意义 年级
P/S 1.8 8
P/BV 1.62 8
P/E 9.69 9
EV/EBITDA -6.64 0
全部的: 7.75

效率

姓名 意义 年级
ROA, % -18.26 0
ROE, % -33.98 0
全部的: 0

股息

姓名 意义 年级
Div yield, % 0 0
DSI 0.7 7
全部的: 3.43

责任

姓名 意义 年级
Debt/EBITDA -0.875 10
全部的: 10

成长冲动

姓名 意义 年级
盈利能力 Revenue, % 348.32 10
盈利能力 Ebitda, % 429.54 10
盈利能力 EPS, % 274.4 10
全部的: 10

ETF分享, %本年盈利能力, %股息, %
iShares Micro-Cap ETF 0.00983 17.09 1.54048
0.0117.091.54



导师 职称 支付 出生年份
Mr. Ted William Karkus Chairman & CEO 902.2k 1959 (66 年)
Mr. Sergio Miralles Executive VP & Chief Information Officer N/A
Mr. Kamal Obbad Senior VP and Director of Sales & Marketing - Nebula Genomics N/A
Mr. Jason Karkus President of Nebula Genomics N/A
Mr. Jed A. Latkin Chief Operating Officer & Head of Finance Department N/A 1974 (51 年)
Mr. Lance Bisesar Corporate Controller

地址: United States, Garden City. NY, 711 Stewart Avenue - 在 Google 地图中打开, 打开 Yandex 地图
网站: https://www.prophaselabs.com